MAY 08, 2019 11:38 AM PDT

Promising treatment for severe dry eye disease

WRITTEN BY: Nouran Amin

In a study published in Translational Vision Science and Technology, a phase I/II clinical trial involving a novel enzyme-based treatment for severe dry eye disease has showed significant improvement in reduced signs of the disease along with a reduction in discomfort.

Normally, enzymes present in tears chop up and clear DNA and other debris on the cornea, but in patients with dry eye disease, there is not enough DNase to clear the material.

The clinical study compared eye drops containing a biosynthetic form of an enzyme called DNase—which breaks up nucleic acid-based material on eye surfaces--with eye drops did not include the DNase enzyme.

"Participants in the trial who used the drops with DNase reported less eye discomfort and their corneas were healthier," said Dr. Sandeep Jain, professor of ophthalmology and visual sciences in the University of Illinois at Chicago College of Medicine and principal investigator of the clinical trial.

For patients with dry eye disease, there is not enough natural DNase enzyme present in their tears to clear the debris that accumulates on the cornea--the transparent outer layer of the eye. The disease is characterized by a dysregulation of tear production and inflammation of the cornea—which can lead to eye pain that is often disabling.

"In dry eye disease, several things happen," Jain explained. "There is an increase in the number of white blood cells called neutrophils that gather on the surface of the eye. Neutrophils release DNA which forms webs on the cornea called neutrophil extracellular traps, which cause inflammation of the ocular surface and attract additional neutrophils in a vicious cycle."

Learn more about dry eye disease:

"The data from this early clinical trial suggests that DNase eye drops may be safe and effective for treating severe dry eye, and we look forward to conducting larger randomized trials to definitively prove its efficacy," Jain said.

DNase is currently approved by the U.S. Food and Drug Administration for the treatment of cystic fibrosis and considered experimental for treating dry eye disease.

"The burden of severe dry eye is much greater than just having an occasional feeling of dryness," Jain said. "It can severely compromise quality of life to the point of disability and can compromise a person's vision. There are currently only two approved drugs to treat dry eye, and they don't work for everyone, especially those with severe disease, so having a new drug that can treat the disease is very important."

Source: University of Illinois at Chicago

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 18, 2019
Health & Medicine
SEP 18, 2019
Dietary Supplements are Severely Harmful for Young Adults
Young people are a target market for dietary supplements for weight loss, muscle building, energy, and more. A team of researchers aimed to determine the r...
SEP 18, 2019
Cell & Molecular Biology
SEP 18, 2019
Scientists Discover Why Arteries Harden & Find a Potential Treatment
As we get older, our arteries slowly begin to stiffen and then harden, which can lead to many serious complications. Now there may be a way to treat it....
SEP 18, 2019
Drug Discovery
SEP 18, 2019
'Sugar-coating' proteins to treat pancreatitis?
A powerful biomarker created by complex sugar molecules, called CA19-9, may be a target for the treatment of pancreatitis. Pancreatitis is an inflammatory ...
SEP 18, 2019
Health & Medicine
SEP 18, 2019
High Risk: Seizures and Coma Linked to Use of Synthetic Cannabinoids in Adolescents
A recent study by the American Academy of Pediatrics states that exposure to acute synthetic cannabinoid toxicity is far more dangerous to the adolesc...
SEP 18, 2019
Genetics & Genomics
SEP 18, 2019
DNA Construction Kit Could Drive Down Costs of Immune Therapy
Researchers at KU Leuven in Belgium have created a DNA construction kit that, when injected into muscle cells, enables sheep to produce new antibodies to f...
SEP 18, 2019
Genetics & Genomics
SEP 18, 2019
Can Lifestyle Changes Switch Off Dementia Genes?
Around 50 million people have dementia worldwide, with 10 million new cases emerging each year (World Health Organization: 2019). Most prominent in people ...
Loading Comments...